Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanofi and Seagen to develop and commercialize antibody-drug conjugates for cancer targets

March 17, 2022

ETC-642 increases plasma HDL and protects mice from sepsis

March 17, 2022

PepGen presents promising preclinical data for PGN-EDO51

March 17, 2022

Discovery of novel S1PR2 ligands as tracers for neuroimaging

March 17, 2022

Blood stem cells treat brain disease after transplant

March 17, 2022

RGX-202 improves muscle function and dystrophic muscle pathology in mice

March 17, 2022

New GSK-3 inhibitors patented by Ramot at Tel Aviv University, Bar-Ilan University

March 17, 2022

New rat model may shed light on mechanisms behind CSVD pathogenesis

March 17, 2022

TIMP-1 and CKM are biomarkers of treatment response in DMD

March 17, 2022

Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides

March 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...